ReachMD

Be part of the knowledge.™

Oncology - Hematology

88

LikeLikedUnlike

Episodes 1-15 of 33

- Jennifer Caudle, DO
  Peer
- Keith McCrae, MD
  Peer
3
Medical Industry Feature
Key Recommendations for ITP: Updates on Management & Treatment from the 2019 ASH Guidelines
Key Recommendations for ITP: Updates on Management & Treatment from the 2019 ASH Guidelines
- Jeffrey V. Matous, MD
  Peer
2
Medical Industry Feature
Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy
Treating Relapsed/Refractory Multiple Myeloma with a Triplet Therapy
- Tracey Evans, MD
  Peer
- Raja Mudad, MD
  Peer
2
Medical Industry Feature
Patient Case Study: A First-Line Treatment Approach in Extensive-Stage Small Cell Lung Cancer
Patient Case Study: A First-Line Treatment Approach in Extensive-Stage Small Cell Lung Cancer
- Tracey Evans, MD
  Peer
- Raja Mudad, MD
  Peer
1
Medical Industry Feature
An Immunotherapy Combination as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
An Immunotherapy Combination as a First-Line Treatment for Extensive-Stage Small Cell Lung Cancer
- Jennifer Caudle, DO
  Peer
- Daniel Johnson, MD
  Peer
1
Medical Industry Feature
Hypothetical Patient Case Study for a Treatment Regimen for Adults With BRAF V600E/K–Mutant Unresectable or Metastatic Melanoma
Hypothetical Patient Case Study for a Treatment Regimen for Adults With BRAF V600E/K–Mutant Unresectable or Metastatic Melanoma
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Steven Fein, MD
  Peer
3
Medical Industry Feature
Expert Insights on ITP: Moving from First to Second-Line Treatment Options
Expert Insights on ITP: Moving from First to Second-Line Treatment Options
- Jennifer Caudle, DO
  Peer
- Pauline Funchain, MD
  Peer
0
Medical Industry Feature
Clinical Trial Data for a Treatment Regimen for Adults With BRAF V600E/K-Mutant Unresectable or Metastatic Melanoma
Clinical Trial Data for a Treatment Regimen for Adults With BRAF V600E/K-Mutant Unresectable or Metastatic Melanoma
- Jennifer Caudle, DO
  Peer
- Tracey Evans, MD
  Peer
1
Medical Industry Feature
Reevaluating Outlooks for Small Cell Lung Cancer
Reevaluating Outlooks for Small Cell Lung Cancer
- Joel Wedd MD, MPH
  Peer
2
Medical Industry Feature
Investigating the Rise of Liver Cancer
Investigating the Rise of Liver Cancer
- John J. Russell, MD
  Peer
- Fadi Braiteh, MD
  Peer
- Jacob Kettle, PharmD
  Peer
0
Medical Industry Feature
Preventing Bone Complications in Breast Cancer Patients with Bone Metastases
Preventing Bone Complications in Breast Cancer Patients with Bone Metastases
- Andy Arwari, MD
  Peer
6
Medical Industry Feature
How Hospice Can Help Home-Based Care Happen
How Hospice Can Help Home-Based Care Happen
- Matt Birnholz, MD
  Peer
- Christopher P. Evans, M.D., F.A.C.S.
  Peer
- Maha Hussain, MD, FACP, FASCO
  Peer
3
Medical Industry Feature
The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape
The Evolution of the Metastatic Prostate Cancer and Non-metastatic Castration-Resistant Prostate Cancer Landscape
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Nicole Lamanna, MD
  Peer
1
Medical Industry Feature
What to Know About a Treatment Option That Targets BCL2
What to Know About a Treatment Option That Targets BCL2
- Jennifer Caudle, DO
  Peer
- Coy Heldermon, MD, PhD
  Peer
- Heather Lau, MD, MS
  Peer
8
Medical Industry Feature
How Can We Prevent the Delayed Diagnosis of Type 1 Gaucher Disease?
How Can We Prevent the Delayed Diagnosis of Type 1 Gaucher Disease?
- Charles Turck, PharmD, BCPS, BCCCP
  Peer
- Harry Paul Erba, MD, PhD
  Peer
- Uma Borate, MD, MS
  Peer
2
Medical Industry Feature
Advances in AML: The Role of a Targeted Therapy in Current Treatment Paradigms
Advances in AML: The Role of a Targeted Therapy in Current Treatment Paradigms

Programs 9/28/21

Segment Chapters

Playlist:

Recommended